Loss of muscle mass can reduce metabolic flexibility and glucose utilization
While long-term weight loss is the goal for gout management, the process of losing weightespecially if it happens quicklycan actually trigger a flare
Together, we can make a difference
This impending patent cliff is a material headwind for Novo Nordisk, but price reductions will drive a substantial uplift in the volume of patients on injectable semaglutide, through preferential reimbursement (by state or PMI payors) and improved affordability for the self-pay segment
Written by: Anela Martinovi, PhD, together with Gali Artzi, PhD, Eva Everloo, Nurit Ben, & Taire Brown The Rise of GLP-1 Just a few short years ago, the term GLP-1 or Ozempic would have meant little to the average person
There is no clear evidence that Wegovy passes into human breast milk in significant amounts but there is not enough research to confirm that it does not